EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances

Chen Deng, Zhongpeng Fan, Yangyang Xu, Miaomiao Cao, Jie Liao, Meng Meng

Bioengineering · 30.06.2026 · 13 (7) · 767

DOI: 10.3390/bioengineering13070767 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 30.06.2026. Verfasst von Chen Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Institute of Synthetic Biology-Canada, Toronto, ON L3R 0B8, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Internal Research Fund of the International Institute of Synthetic Biology - Canada, Internal Research Fund of the International Institute of Synthetic Biology—Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide therapeutics offer high target selectivity and low toxicity, but their clinical utility remains constrained by rapid proteolysis in vivo and negligible oral bioavailability. Incorporating non-canonical amino acids (ncAAs) provides a robust molecular engineering framework to overcome these pharmacokinetic bottlenecks. This review analyzes the structural and biophysical design rules of ncAA-mediated peptide stabilization, categorizing them into side-chain steric shielding, backbone conformational constraint, and stereochemical evasion of L-specific proteases. We systematically evaluate the biosynthetic milestones enabling this field, focusing on engineered orthogonal translation systems (tRNA/synthetase pairs, orthogonal ribosomes, quadruplet codons) and metabolic engineering strategies that supply fluorinated and other ncAA precursors de novo. Furthermore, we examine the translation of these technologies into clinical candidates (e.g., modified antimicrobial peptides, antibody–drug conjugates, and PROTACs) and identify scaling, immunogenicity, and computational modeling as key bottlenecks. This review serves as a technical reference for designing next-generation, hyper-stable peptide therapeutics.

Schlagwörter

Stichwörter der Autor:innen

genetic code expansionmetabolic engineeringnon-canonical amino acidspeptide therapeuticsprotease-resistant peptidessynthetic biology

Autor:innen und Institutionen

  • International Institute of Synthetic Biology-Canada, Toronto, ON L3R 0B8, Canada.
  • Norman Bethune International Institute of Canada for Healthcare Innovation, Toronto, ON L3R 0B8, Canada.
  • State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Food Nutrition and Safety, Ministry of Education, College of Food Engineering and Biotechnology, Tianjin University of Science and Technology, Tianjin…

Förderung

  • the Internal Research Fund of the International Institute of Synthetic Biology - Canada
  • Internal Research Fund of the International Institute of Synthetic Biology—Canada

Zitieren

APA

Deng, C., Fan, Z., Xu, Y., Cao, M., Liao, J., & Meng, M. (2026). Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances. Bioengineering, 13(7), 767. https://doi.org/10.3390/bioengineering13070767

Vancouver

Deng C, Fan Z, Xu Y, Cao M, Liao J, Meng M. Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances. Bioengineering. 2026;13(7):767. doi:10.3390/bioengineering13070767

BibTeX
@article{Deng2026,
  author = {Deng, Chen and Fan, Zhongpeng and Xu, Yangyang and Cao, Miaomiao and Liao, Jie and Meng, Meng},
  title = {Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances},
  journal = {Bioengineering},
  year = {2026},
  volume = {13},
  number = {7},
  pages = {767},
  doi = {10.3390/bioengineering13070767}
}
Kostenlos starten →